Eric Chen, co-founder and chief executive officer of Injective (INJ), stated that he anticipates exchange-traded funds linked to the Layer 1 blockchain’s native token INJ to debut in the United States prior to 2027.
“I cannot specify an exact timeframe, but 2027 feels slightly too distant,” Chen remarked during a conversation with The Block at Korea Blockchain Week 2026. “It is actually arriving much sooner than I anticipated as well, so we shall see.”
Based on information from the Securities and Exchange Commission portal, there are currently two ETF proposals connected to INJ, namely the 21Shares Injective ETF and the Originally published at https://www.theblock.co/news/defi/2026-10-05-injective-ceo-eric-inj-etf-417616.
